Praised for exhibiting ‘deep industry knowledge’, Carpmaels & Ransford LLP is noted for assisting clients with trade marks, data protection, and orphan exclusivities. David Wilson has a great deal of experience in handling patent disputes concerning license agreements, and the ‘very talented and extremely dedicated’ Jennifer Antcliff regularly appears before the Court of Appeal, Supreme Court, and the CJEU in SPC cases. Jake Marshall primarily focuses on transactional IP matters, and Hugh Goodfellow is particularly adept at the filing and prosecution of SPCs, and oppositions. James Warner leads on the chemical and pharmaceutical side, frequently handling EPO opposition proceedings. Mark Chapman heads up the biotech team, and has vast experience in pre and post-grant proceedings before the EPO.
Testimonials
Collated independently by Legal 500 research team.
‘Very good pharmaceutical patent practice, unsurprising given the client portfolio in the patent attorney side of the firm.’
‘C&R's strength is its fusion of a solicitors' practice with a patent attorneys' practice, meaning that it can provide a one-stop shop for prosecution and litigation of patents.’
‘Jenny Antcliff is a very talented and extremely dedicated and diligent junior partner.'
‘Deep industry knowledge. Able to explain difficult concepts in an accessibly way. Strategic thinking and scenario planning.’
‘Carpmaels has a team of very talented patent attorneys and litigators that are both experienced in patent law and have high level of technical expertise, and that work in a very collaborative way.’
‘Camilla Balleny is very thoughtful and comprehensive in her identification and analysis of legal issues, and she is very good about keeping the client informed and involving the client in strategic decision making.'
Key clients
- Johnson & Johnson group
- Bristol Myers Squibb
- FibroGen, Inc.
- Janssen-Cilag Limited
- Janssen Pharmaceuticals
- Janssen Oncology
- Takeda
- Ionis Pharmaceuticals, Inc.
- Regeneron Pharmaceuticals, Inc.
- Gilead
- Stichting Hubrecht Organoid Technology
- Incyte
- Biogen Inc.
- Align Technology
- Novartis
- Vertex
- Jazz Pharmaceuticals
- CSL
- LifeScan, Inc.
- Ethicon Inc. & Ethicon LLC
- McNeil AB
- Acorda Therapeutics
- Biosense Webster
- Abbott Laboratories
- Raytheon Technologies Corporation
- LEO Pharma
- Afiniti, Ltd.
- Auris Health
- Quantum-Si
- Amgen
Work highlights
- Acted for FibroGen in FibroGen Inc. v Akebia Therapeutics Inc. and Others, in which the Court of Appeal found that FibroGen’s patents were valid on the ground of sufficiency.
- Acting for Janssen Pharmaceutica in SPC and dosage regimen patent defence relating to blockbuster product XEPLION.
- Advising FabricNano on a patent licensing and master services agreement to safeguard the foundation of its technology and providing the contractual framework for commercialising that technology.
Lawyers
Practice head
The lawyer(s) leading their teams.
David Wilson, Jake Marshall, Hugh Goodfellow, James Warner, Mark Chapman, Roger Lush